Clinical trial
Effect of Self Assembling Peptide P11-4 in Patients With Early Occlusal Carious Lesions: A Mono-centre, Controlled, Single-blinded, Randomised Study
NCT02724592 is registered in ClinicalTrials.gov with University Medicine Greifswald as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Self Assembling Peptide P11-4 in Patients With Early Occlusal Carious Lesions: A Mono-centre, Controlled, Single-blinded, Randomised Study
- Lead sponsor
- University Medicine Greifswald
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- February 28, 2013
- Completion date
- October 31, 2014
- Enrollment
- 70 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.